Ashwagandha for Stress — What the Clinical Evidence Shows

The Adaptogen Framing Problem

Ashwagandha is typically marketed as an adaptogen — a vague term that implies the substance helps the body adapt to stress without specifying mechanism. The framing is not wrong, but it obscures the actual pharmacology. Ashwagandha primary active compounds are withanolides, which appear to act on the hypothalamic-pituitary-adrenal axis to reduce cortisol output under chronic stress conditions.

What the Studies Actually Show

A 2019 randomized controlled trial in Medicine used 240 mg of a standardized ashwagandha extract over 60 days and found a statistically significant reduction in serum cortisol, perceived stress, and anxiety. A 2012 study in the Indian Journal of Psychological Medicine using 300 mg twice daily of a root extract showed similar results. The effect size is moderate but the evidence is better than most supplements in this category.

Who Benefits Most

The cortisol-lowering effect is most pronounced in people with elevated baseline cortisol — which correlates with chronic stress, poor sleep, and high training loads. People with normal cortisol levels see less benefit.

Form and Dose

KSM-66 (a full-spectrum root extract standardized to 5% withanolides) is the most studied commercial form. Standard research doses range from 240 to 600 mg daily.

The Recovery Stack Connection

Cortisol suppresses muscle protein synthesis and disrupts sleep. Managing chronic stress directly affects training adaptation. Ashwagandha as a daily recovery tool pairs logically with adequate protein and sleep hygiene. Genesee product roadmap includes recovery extensions that address the cortisol piece directly.